Crouse Health Online: Wellness is just a click away.
Share Share
  |  Connect with Us: 
large
med
small
Text Size
 

Health News



Blood Test May Help Predict Spread of Melanoma

Blood Test May Help Predict Spread of Melanoma

04/15/11

FRIDAY, April 15 (HealthDay News) -- It's possible that a blood test could be used to predict the risk of cancer spreading, or metastasizing, in people who have melanoma skin cancer, a new study suggests.

Researchers from Yale University tested the blood of 108 people with metastatic melanoma and 108 people with stage 1 or 2 melanoma and found that those with metastatic disease had higher levels of several biomarkers.

Though 83 percent of people with metastatic cancer had elevations of at least one of the markers, there were no elevations in 76 percent of those with early-stage cancer, the investigators found.

The study findings are reported in the April 15 issue of Clinical Cancer Research.

"This finding will need to be confirmed prospectively before it is used in the clinic, but it shows that such testing is possible," Dr. Harriet Kruger, an associate professor of medicine at Yale, said in a news release from the American Association for Cancer Research.

Being able to use a blood test to predict the risk of metastasis in people with melanoma would be cheaper than the current method of monitoring, which includes periodic imaging tests, physical examinations and blood tests, the researchers said.

Dr. Iman Osman, director of the interdisciplinary melanoma program at the NYU Langone Medical Center in New York City, described the idea of a blood test for metastatic melanoma as "important and clinically relevant."

"The data are interesting; however, there are several questions that remain to be answered," Osman said. "Can the panel of markers predict recurrence at the time of diagnosis, and [is] the combination of markers . . . better than the standard of care?"

According to the association, 68,130 people in the United States were diagnosed with melanoma in 2010, and 8,700 died of the disease. Most deaths from melanoma are the result of metastasis. The risk of metastasis ranges from less than 10 percent for patients with stage 1A melanoma to as high as 70 percent for those with stage 3C.

More information

The American Academy of Family Physicians has more about melanoma.

Copyright © 2011 HealthDay. All rights reserved.

Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.

OF INTEREST:
 

Latest News

Crouse Hospital First in Region to Use New da Vinci Xi Surgical System
more >

MedEx Bedside Prescription Delivery Service

Free service offers convenience, patient education at discharge.
more >

CrouseSports Express After-Hours Ortho Care

Immediate care of orthopedic injuries in kids and adults.
more >

Weight Loss Surgery

Is it right for you? Attend a free information seminar held twice monthly.
more >

Quality at Crouse

See how Crouse Hospital strives to provide the best in patient care.
more >

Cheer Up That Special Someone

Say get well or welcome a new arrival with a gift purchased right at Crouse.

more >

Make an Online Donation Now

Your donation of any amount helps support Crouse services & programs in a meaningful way.
more >

Shop Online Now

Say get well, thinking of you or welcome new baby with a unique gift from the Crouse Gift Shop.

more >